It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ferroptosis is associated with lipid hydroperoxides generated by the oxidation of polyunsaturated acyl chains. Lipid hydroperoxides are reduced by glutathione peroxidase 4 (GPX4) and GPX4 inhibitors induce ferroptosis. However, the therapeutic potential of triggering ferroptosis in cancer cells with polyunsaturated fatty acids is unknown. Here, we identify conjugated linoleates including α-eleostearic acid (αESA) as ferroptosis inducers. αESA does not alter GPX4 activity but is incorporated into cellular lipids and promotes lipid peroxidation and cell death in diverse cancer cell types. αESA-triggered death is mediated by acyl-CoA synthetase long-chain isoform 1, which promotes αESA incorporation into neutral lipids including triacylglycerols. Interfering with triacylglycerol biosynthesis suppresses ferroptosis triggered by αESA but not by GPX4 inhibition. Oral administration of tung oil, naturally rich in αESA, to mice limits tumor growth and metastasis with transcriptional changes consistent with ferroptosis. Overall, these findings illuminate a potential approach to ferroptosis, complementary to GPX4 inhibition.
Inhibition of the lipid peroxidase GPX4 promotes ferroptotic cell death. Here, the authors identify a complementary approach using conjugated linolenic fatty acids that trigger lipid peroxidation and ferroptosis via ACSL1, DGAT1/2, and neutral lipids.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Fox Chase Cancer Center, Philadelphia, USA (GRID:grid.249335.a)
2 University of Pittsburgh, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Center for Free Radical and Antioxidant Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
3 Drexel University College of Medicine, Department of Biochemistry and Molecular Biology, Philadelphia, USA (GRID:grid.166341.7) (ISNI:0000 0001 2181 3113)
4 Helmholtz Zentrum München, Institute of Metabolism and Cell Death, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
5 Helmholtz Zentrum München, Institute of Metabolism and Cell Death, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); National Research Medical University, Laboratory of Experimental Oncology, Moscow, Russia (GRID:grid.4567.0)
6 Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34)
7 University of Pittsburgh, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Center for Free Radical and Antioxidant Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Critical Care Medicine, Safar Center for Resuscitation Research, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
8 University of Pittsburgh, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Center for Free Radical and Antioxidant Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Chemistry, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Pharmacology and Chemical Biology, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Department of Radiation Oncology, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); IM Sechenov Moscow State Medical University, Laboratory of Navigational Redox Lipidomics, Moscow, Russia (GRID:grid.448878.f) (ISNI:0000 0001 2288 8774)
9 Metanomics Health GmbH, Berlin, Germany (GRID:grid.3319.8) (ISNI:0000 0001 1551 0781)